ALDX
insider transactionsAldeyra Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+250.0K
250.0K buy · 0 sell
Net value · 90d
$418.4K
$418.4K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
1
250.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
3.3K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
19.9K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
5.0K sh
Own New
-
Grant·A
Director
$0
6.6K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
5.0K sh
Own New
-
Grant·A
Director
$0
5.3K sh
Own New
-
Grant·A
Director
$0
70.0K sh
Own New
-
Grant·A
Director
$0
9.8K sh
Own New
-
Grant·A
Director
$0
84.6K sh
Own New
-
Buy·P
Todd C Brady KEY
President and CEO
$418.4K
250.0K sh · $1.67
Own +17%
-
Grant·A
Todd C Brady KEY
President and CEO
$0
632.3K sh
Own New
-
Grant·A
Todd C Brady KEY
President and CEO
$0
1.9M sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Nancy Miller-Rich | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Nancy Miller-Rich | Grant A | 70.0K | $0 |
| Jun 9, 2026 | DOUGLAS RICHARD | Grant A | 2.3K | $0 |
| Jun 9, 2026 | DOUGLAS RICHARD | Grant A | 19.9K | $0 |
| Jun 9, 2026 | DOUGLAS RICHARD | Grant A | 70.0K | $0 |
| Jun 9, 2026 | Gary M. Phillips | Grant A | 5.0K | $0 |
| Jun 9, 2026 | Gary M. Phillips | Grant A | 6.6K | $0 |
| Jun 9, 2026 | Gary M. Phillips | Grant A | 70.0K | $0 |
| Jun 9, 2026 | William D Clark | Grant A | 2.3K | $0 |
| Jun 9, 2026 | William D Clark | Grant A | 70.0K | $0 |
| Jun 9, 2026 | Neal Walker | Grant A | 3.3K | $0 |
| Jun 9, 2026 | Neal Walker | Grant A | 70.0K | $0 |
| Jun 9, 2026 | Ben Bronstein | Grant A | 5.0K | $0 |
| Jun 9, 2026 | Ben Bronstein | Grant A | 5.3K | $0 |
| Jun 9, 2026 | Ben Bronstein | Grant A | 70.0K | $0 |
| Jun 9, 2026 | Darlene M Deptula-Hicks | Grant A | 9.8K | $0 |
| Jun 9, 2026 | Darlene M Deptula-Hicks | Grant A | 84.6K | $0 |
| Jun 3, 2026 | Todd C Brady KEY | Buy P | 250.0K | $418.4K |
| Mar 27, 2026 | Todd C Brady KEY | Grant A | 632.3K | $0 |
| Mar 27, 2026 | Todd C Brady KEY | Grant A | 1.9M | $0 |
About ALDX insider trading
This page tracks insider transactions for Aldeyra Therapeutics, Inc. (ALDX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.